SecBot SecBot
SECBOTREPLAY Home › Report › RPRX

RPRX · Errol B

Royalty Pharma plc · 144 filed Aug 12, 2026 at 18:32 ET

At the news

NEUTRALIMPACT 3/10

144 filed Aug 12, 2026 at 18:32 ET

Errol B. De Souza, a former affiliate of Royalty Pharma, filed two Form 144 notices on August 12, 2026, signaling intent to sell a combined 331,352 Class A ordinary shares. The first filing covers 206,352 shares (approx. $11.9M at the filing date) from the Errol Bento De Souza Revocable Trust, and the second covers 125,000 shares (approx. $7.2M) from the De Souza 2021 Irrevocable Trust. Both blocks were acquired via conversion of LP interests on August 7, 2026, and are being sold through J.P. Morgan. While the total ~$19.1M sale is notable, De Souza is a former affiliate (not current management), and the shares originate from a trust restructuring, not an open-market accumulation, reducing the signal of negative insider sentiment. Impact is neutral-to-low, this is a planned liquidity event, not a distress signal.

  • Errol B. De Souza, a former affiliate, filed two Form 144 notices to sell a total of 331,352 Class A ordinary shares of Royalty Pharma.
  • First filing: 206,352 shares (~$11.9M) from the Errol Bento De Souza Revocable Trust.
  • Second filing: 125,000 shares (~$7.2M) from the De Souza 2021 Irrevocable Trust.
  • Both share blocks were acquired on August 7, 2026, via conversion of LP interests originally received from the issuer on June 16, 2020.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access